Allogeneic Cell Therapy Innovations
We discussed the potential of allogeneic therapies across oncology and non-oncology and featured insights on leading developers, therapeutic classes, and current targets. Additionally, our industry experts provided an overview of clinical market trends, regulatory landscapes, and strategic considerations to help stakeholders make informed decisions. Watch the recording now.
Our Experts
Rachel East
House Speaker
Senior Research Analyst
Beacon
Ahmed Tajmohamed
House Speaker
Market Analyst
Hanson Wade Intelligence
Thomas Vickers
Moderator
Account Manager
Beacon
You May Also Be Interested In…
Where ADC Innovation Is Going: Multispecific & Multipayload Landscapes Unpacked
View Webinar
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
